The proposed rule would require that short-term plans are truly short-term and are active for just three months.

Three cardiology societies have reached out to CMS with questions about how MACs are interpreting a policy related to shared decision-making. 

The estimated increase is driven by multiple factors, including labor shortages, provider contract negotiations and rising drug prices.

That's according to new data from AMGA Consulting’s 36th annual Medical Group Compensation and Productivity Survey, which includes data from 446 medical groups, representing over 193,000 providers.

The Drug Price Negotiation Program already has changed how the company considers the development of future oncology programs and medications. 

Prior to March and April of 2023, operating margins sat in the red for 15 consecutive months.

“This research shows the clear financial benefits when hospitals and health systems offer telemedicine services directly to their own employees."

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.